为什么WAIT计划是糖尿病体重管理的一种新模式

O. Hamdy, A. Goebel-Fabbri, C. Carver, Gillian Arathuzik, J. Shahar, R. Capelson, J. Beaton, S. O’Donnell, Nuha El-Sayed, J. Mitri, Voula Mentzelopoulos, M. Abrahamson
{"title":"为什么WAIT计划是糖尿病体重管理的一种新模式","authors":"O. Hamdy, A. Goebel-Fabbri, C. Carver, Gillian Arathuzik, J. Shahar, R. Capelson, J. Beaton, S. O’Donnell, Nuha El-Sayed, J. Mitri, Voula Mentzelopoulos, M. Abrahamson","doi":"10.1089/OBE.2008.0206","DOIUrl":null,"url":null,"abstract":"The prevalence of overweight and obesity has increased rapidly among U.S. adults, and in particular, among those diagnosed with type 2 diabetes mellitus (T2DM). Data from the 1999–2002 National Health and Nutrition Examination Survey (NHANES) indicate that the prevalence of overweight and obesity among U.S. adults with diabetes now exceeds 85%. We previously demonstrated that modest weight reduction of approximately 7% over a 6-month period through caloric reduction and increased physical activity improved insulin sensitivity, endothelial function, and several markers of inflammation and coagulation in obese patients with and without diabetes.1,2 The ongoing Look AHEAD (Action for Health in Diabetes) study is exploring the health outcomes associated with modest weight loss maintained over 10 years using an intensive lifestyle intervention (ILI) that combines decreased caloric intake, increased physical activity, and behavior modification versus standard diabetes support and education (DSE) in patients with T2DM. The Look AHEAD study group recently published their first-year results, which are encouraging.3 They found that participants randomized to ILI lost an average of 8.6% of their initial body weight compared with 0.7% in the DSE group. Although both groups experienced blood glucose reductions compared to baseline, A1c improvement in the ILI group was significantly greater than that observed in the DSE group (absolute A1c reduction: −0.64% [ILI] versus −0.14% [DSE], p < 0.001; baseline A1c for both groups: ~7.3%). Notably, A1c lowering was Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice","PeriodicalId":88288,"journal":{"name":"Obesity management","volume":"4 1","pages":"176-183"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/OBE.2008.0206","citationCount":"18","resultStr":"{\"title\":\"Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice\",\"authors\":\"O. Hamdy, A. Goebel-Fabbri, C. Carver, Gillian Arathuzik, J. Shahar, R. Capelson, J. Beaton, S. O’Donnell, Nuha El-Sayed, J. Mitri, Voula Mentzelopoulos, M. Abrahamson\",\"doi\":\"10.1089/OBE.2008.0206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The prevalence of overweight and obesity has increased rapidly among U.S. adults, and in particular, among those diagnosed with type 2 diabetes mellitus (T2DM). Data from the 1999–2002 National Health and Nutrition Examination Survey (NHANES) indicate that the prevalence of overweight and obesity among U.S. adults with diabetes now exceeds 85%. We previously demonstrated that modest weight reduction of approximately 7% over a 6-month period through caloric reduction and increased physical activity improved insulin sensitivity, endothelial function, and several markers of inflammation and coagulation in obese patients with and without diabetes.1,2 The ongoing Look AHEAD (Action for Health in Diabetes) study is exploring the health outcomes associated with modest weight loss maintained over 10 years using an intensive lifestyle intervention (ILI) that combines decreased caloric intake, increased physical activity, and behavior modification versus standard diabetes support and education (DSE) in patients with T2DM. The Look AHEAD study group recently published their first-year results, which are encouraging.3 They found that participants randomized to ILI lost an average of 8.6% of their initial body weight compared with 0.7% in the DSE group. Although both groups experienced blood glucose reductions compared to baseline, A1c improvement in the ILI group was significantly greater than that observed in the DSE group (absolute A1c reduction: −0.64% [ILI] versus −0.14% [DSE], p < 0.001; baseline A1c for both groups: ~7.3%). Notably, A1c lowering was Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice\",\"PeriodicalId\":88288,\"journal\":{\"name\":\"Obesity management\",\"volume\":\"4 1\",\"pages\":\"176-183\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1089/OBE.2008.0206\",\"citationCount\":\"18\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/OBE.2008.0206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/OBE.2008.0206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

摘要

超重和肥胖的患病率在美国成年人中迅速增加,特别是在那些被诊断为2型糖尿病(T2DM)的人群中。1999-2002年全国健康与营养调查(NHANES)的数据表明,美国成年糖尿病患者中超重和肥胖的患病率现已超过85%。我们之前的研究表明,在6个月的时间里,通过减少热量和增加体力活动,体重适度减轻约7%,改善了有或没有糖尿病的肥胖患者的胰岛素敏感性、内皮功能和一些炎症和凝血指标。1,2正在进行的前瞻性(糖尿病健康行动)研究正在探索T2DM患者使用强化生活方式干预(ILI)与标准糖尿病支持和教育(DSE)相结合,减少热量摄入,增加身体活动和行为改变,维持适度体重超过10年的健康结果。“展望未来”研究小组最近公布了他们第一年的研究结果,令人鼓舞他们发现,随机分配到ILI组的参与者平均减轻了其初始体重的8.6%,而DSE组则为0.7%。虽然两组血糖均较基线降低,但ILI组的A1c改善明显大于DSE组(A1c绝对降低:- 0.64% [ILI]对- 0.14% [DSE], p < 0.001;两组基线A1c: ~7.3%)。值得注意的是,A1c降低是为什么WAIT计划:在常规临床实践中糖尿病体重管理的新模式
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice
The prevalence of overweight and obesity has increased rapidly among U.S. adults, and in particular, among those diagnosed with type 2 diabetes mellitus (T2DM). Data from the 1999–2002 National Health and Nutrition Examination Survey (NHANES) indicate that the prevalence of overweight and obesity among U.S. adults with diabetes now exceeds 85%. We previously demonstrated that modest weight reduction of approximately 7% over a 6-month period through caloric reduction and increased physical activity improved insulin sensitivity, endothelial function, and several markers of inflammation and coagulation in obese patients with and without diabetes.1,2 The ongoing Look AHEAD (Action for Health in Diabetes) study is exploring the health outcomes associated with modest weight loss maintained over 10 years using an intensive lifestyle intervention (ILI) that combines decreased caloric intake, increased physical activity, and behavior modification versus standard diabetes support and education (DSE) in patients with T2DM. The Look AHEAD study group recently published their first-year results, which are encouraging.3 They found that participants randomized to ILI lost an average of 8.6% of their initial body weight compared with 0.7% in the DSE group. Although both groups experienced blood glucose reductions compared to baseline, A1c improvement in the ILI group was significantly greater than that observed in the DSE group (absolute A1c reduction: −0.64% [ILI] versus −0.14% [DSE], p < 0.001; baseline A1c for both groups: ~7.3%). Notably, A1c lowering was Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nutritional Approaches and Self-Monitoring Postoperative Management and Nutritional Deficiencies Melanocortin 4 Receptor (MC4R) Deficiency Choosing a Medication Diagnosing Type II Diabetes and Choosing Medications in Patients with Obesity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1